1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
CAVA reported fourth-quarter and fiscal 2024 results, with revenue, net income and adjusted EBITDA all higher than in the prior year. Fourth-quarter net income of $78.6 million includes an $80.1 million benefit from releasing a valuation allowance on deferred tax assets, and excluding it, adjusted net income was $6.5 million. The company also gave fiscal 2025 guidance for adjusted EBITDA of $150.0 million to $157.0 million.
Fourth-quarter CAVA Revenue rose 28.3% to $225.1 million; fiscal 2024 CAVA Revenue rose 33.1% to $954.3 million
Fiscal 2024 net income was $130.3 million versus $13.3 million in fiscal 2023; excluding the VA Release, adjusted net income was $50.2 million
Fiscal 2025 guidance: adjusted EBITDA of $150.0 million to $157.0 million and CAVA Same Restaurant Sales Growth of 6.0% to 8.0%, compared with 13.4% in fiscal 2024
Merit Medical reported fourth-quarter and full-year 2024 results on February 25, 2025, with revenue up 9.4% in the quarter and 7.9% for the year. The company also issued 2025 guidance calling for revenue of $1.470 billion to $1.490 billion and non-GAAP earnings per share of $3.58 to $3.70, up 8% to 10% and 4% to 7% from 2024. GAAP earnings per share in the quarter slipped to $0.46 from $0.47 a year earlier.
Q4 2024 revenue was $355.2 million, up 9.4%; GAAP net income was $27.9 million, or $0.46 per diluted share, versus $0.47 a year earlier
Q4 2024 non-GAAP EPS was $0.93, up 25.8% from the prior year period
Full-year 2024 revenue was $1.357 billion, up 7.9%; GAAP EPS was $2.03 versus $1.62 in 2023
2025 guidance: revenue of $1.470 billion to $1.490 billion and non-GAAP EPS of $3.58 to $3.70
Interparfums reported record fourth-quarter and full-year 2024 results, with full-year net sales up 10% to $1.45 billion and diluted EPS of $5.12, up from $4.75. The company reaffirmed its 2025 guidance and raised its annual cash dividend 7% to $3.20 per share, which shareholders should weigh alongside a $4 million impairment loss tied to Rochas Fashion.
Full-year 2024 net sales rose 10% to $1.45 billion; fourth-quarter net sales were $362 million, up 10%.
Full-year diluted EPS was $5.12, or $5.18 before the $4 million impairment loss, versus the $5.15 guidance the company had given.
2025 guidance calls for net sales of $1.51 billion and EPS of $5.35, both up 4%, and was reaffirmed.
Annual cash dividend rate increased to $3.20 from $3.00; next quarterly dividend of $0.80 is payable March 28, 2025, to holders of record on March 14, 2025.
EXL reported fourth-quarter 2024 revenue of $481.4 million, up 16.3% from a year earlier, and GAAP diluted EPS of $0.31, up from $0.24. For full-year 2024, revenue was $1.84 billion, up 12.7%, and GAAP diluted EPS was $1.21, up from $1.10. The company guided to 2025 revenue of $2.025 billion to $2.060 billion and adjusted diluted EPS of $1.83 to $1.89, implying growth of 10% to 12% and 11% to 14%, respectively.
Q4 2024 revenue $481.4 million, up 16.3%; GAAP diluted EPS $0.31 vs. $0.24; adjusted diluted EPS $0.44 vs. $0.35
Full-year 2024 revenue $1.84 billion, up 12.7%; GAAP diluted EPS $1.21 vs. $1.10; adjusted diluted EPS $1.65 vs. $1.43
2025 guidance: revenue $2.025 billion to $2.060 billion; adjusted diluted EPS $1.83 to $1.89
New reporting segments and an updated operating model take effect in Q1 2025; conference call set for February 26, 2025 at 10:00 A.M. ET
UFP Technologies reported fourth-quarter and full-year 2024 results on February 25, 2025. Full-year net sales rose 26.1% to $504.4 million and GAAP diluted EPS was $7.58, compared with $5.83 in 2023, while fourth-quarter sales grew 41.9% to $144.1 million. Long-term debt, less current portion, was $176.9 million at December 31, 2024, up from $28.0 million a year earlier.
Full-year 2024 net income was $59.0 million, up 31.3% from $44.9 million; GAAP diluted EPS was $7.58 versus $5.83.
Fourth-quarter 2024 net sales were $144.1 million, up 41.9%; GAAP diluted EPS was $2.10 versus $1.51.
Full-year MedTech sales rose 30.2% to $450.8 million; gross margin was 29.1% versus 28.1%.
Long-term debt, less current portion, was $176.9 million at December 31, 2024, versus $28.0 million at December 31, 2023.
SPX Technologies reported fourth-quarter 2024 revenue of $533.7 million, up from $469.4 million, and GAAP diluted EPS of $1.19, up from $0.67. For full-year 2024, GAAP net income rose to $200.5 million from $89.9 million, and the company introduced 2025 full-year adjusted EPS guidance of $6.00 to $6.25. Shareholders get a clear view of stronger 2024 earnings and a 2025 outlook that calls for growth.
Q4 2024 revenue was $533.7 million versus $469.4 million in Q4 2023, and Q4 GAAP diluted EPS was $1.19 versus $0.67.
Full-year 2024 GAAP net income was $200.5 million versus $89.9 million in 2023; full-year adjusted EPS was $5.58 versus $4.31.
2025 guidance targets consolidated revenue of approximately $2.13 to $2.19 billion and adjusted EPS of $6.00 to $6.25.
Keysight reported first quarter fiscal 2025 results for the period ended January 31, 2025, with revenue of $1.30 billion, up from $1.26 billion a year earlier. Non-GAAP earnings per share rose to $1.82 from $1.63, while GAAP net income of $169 million, or $0.97 per share, was slightly below the prior year's $172 million, or $0.98 per share. The company also guided second quarter revenue to $1.27 billion to $1.29 billion and non-GAAP EPS to $1.61 to $1.67.
Revenue was $1.30 billion, compared with $1.26 billion in the first quarter of 2024.
GAAP net income was $169 million, or $0.97 per share, versus $172 million, or $0.98 per share, a year earlier.
Non-GAAP net income was $317 million, or $1.82 per share, versus $286 million, or $1.63 per share.
Second quarter fiscal 2025 guidance: revenue of $1.27 billion to $1.29 billion and non-GAAP EPS of $1.61 to $1.67.
Arcus Biosciences reported fourth-quarter and full-year 2024 results. Full-year revenue rose to $258 million from $117 million and the net loss narrowed to $283 million from $307 million, or $3.14 per share versus $4.15. The company ended the year with $992 million in cash, cash equivalents and marketable securities after completing a $150 million financing, though fourth-quarter net loss widened to $94 million from $81 million.
Full-year 2024 revenue was $258 million, compared with $117 million in 2023
Full-year net loss per share was $3.14, compared with $4.15 in 2023; full-year R&D expenses were $448 million, compared with $340 million
Fourth-quarter 2024 net loss was $94 million, compared with $81 million, on revenue of $36 million versus $31 million
Cash, cash equivalents and marketable securities were $992 million as of December 31, 2024, excluding proceeds from the $150 million financing
Instacart, which files under Maplebear Inc., reported fourth-quarter 2024 results on February 25, 2025, with revenue up 10% year-over-year and GAAP net income up $13 million. The company also gave a first-quarter 2025 outlook calling for adjusted EBITDA of $220 million to $230 million, which it says is up year-over-year, and 2025 stock-based compensation of less than $425 million.
Q4 2024 total revenue was $883 million, up 10% year-over-year, and GTV was $8,645 million, up 10%.
Q4 2024 GAAP net income was $148 million, up $13 million year-over-year; adjusted EBITDA was $252 million, up 27%.
Q4 2024 operating cash flow was $153 million, a decrease of $80 million year-over-year, due to working capital fluctuations.
Q1 2025 outlook: GTV of $9,000 million to $9,150 million and adjusted EBITDA of $220 million to $230 million.
First Solar reported fourth-quarter 2024 net sales of $1.5 billion, up $0.6 billion from the prior quarter, and diluted earnings of $3.65 per share, up from $3.25 a year earlier. The company also gave 2025 guidance of $5.3 billion to $5.8 billion in net sales and $17.00 to $20.00 in earnings per diluted share, which gives shareholders a outlook for the year ahead.
Q4 2024 net sales $1.5 billion; full-year 2024 net sales $4.2 billion, up from $3.3 billion in 2023
Q4 2024 diluted EPS $3.65 vs. $3.25 in Q4 2023; full-year 2024 diluted EPS $12.02 vs. $7.74
2025 guidance: net sales $5.3 billion to $5.8 billion; diluted EPS $17.00 to $20.00; operating income $1.95 billion to $2.30 billion
Year-end 2024 net cash balance of $1.2 billion, up from $0.7 billion at the end of the prior quarter
Intuit reported fiscal second-quarter results for the period ended January 31, 2025, with total revenue of $4.0 billion, up 17 percent, and GAAP diluted earnings per share of $1.67, up 34 percent. The company reiterated its full fiscal 2025 guidance and declared a quarterly dividend of $1.04 per share, a 16 percent increase from the prior-year period.
Global Business Solutions Group revenue rose 19 percent to $2.7 billion; Credit Karma revenue rose 36 percent to $511 million.
Non-GAAP diluted EPS was $3.32, up 26 percent; GAAP operating income was $593 million, up 61 percent.
Full-year fiscal 2025 revenue guidance of $18.160 billion to $18.347 billion was reiterated; third-quarter revenue guidance is $7.550 billion to $7.600 billion.
The $1.04 dividend is payable April 18, 2025, to shareholders of record as of April 10, 2025.
Innovex International reported fourth-quarter 2024 revenue of $251 million, up from $152 million in the third quarter and $133 million a year earlier, and net income of $32 million, compared with $18 million a year earlier. The company also gave first-quarter 2025 revenue guidance of $245 million to $255 million and Adjusted EBITDA guidance of $45 million to $50 million, and its board approved a new $100 million share repurchase program.
Q4 2024 revenue of $251 million, up 65% from Q3 2024 and up from $133 million in Q4 2023; full-year 2024 revenue was $661 million
Q4 2024 net income of $32 million, down from $83 million in Q3 2024 but up from $18 million in Q4 2023; full-year net income was $140 million
Q1 2025 guidance: total revenue of $245 million to $255 million and Adjusted EBITDA of $45 million to $50 million
Board approved a new share repurchase program of up to $100 million on February 25, 2025, replacing prior Dril-Quip plans
MGE Energy reported full-year 2024 net income of $120.6 million, or $3.33 per share, up from $117.7 million, or $3.25 per share, in 2023. Fourth-quarter net income rose to $22.0 million, or 61 cents per share, from $20.1 million, or 55 cents per share, a year earlier. Full-year operating revenues fell to $676.9 million from $690.4 million, which the company attributed in part to warmer-than-normal weather reducing gas deliveries.
Full-year 2024 net income $120.6 million ($3.33 per share) vs. $117.7 million ($3.25) in 2023
Q4 2024 net income $22.0 million (61 cents per share) vs. $20.1 million (55 cents) in Q4 2023
Full-year 2024 operating revenues $676.9 million vs. $690.4 million; Q4 revenues $171.4 million vs. $164.7 million
Gas retail therm deliveries decreased approximately 4% in 2024, mainly due to warmer-than-normal weather
Itron reported fourth-quarter and full-year 2024 results, with revenue up 6% in the quarter to $613 million and up 12% for the year to $2.4 billion. GAAP diluted EPS rose to $1.26 for the quarter and $5.18 for the year, and the company set a record total backlog of $4.7 billion. Its 2025 non-GAAP diluted EPS outlook of $5.20 to $5.60 sits near the $5.62 reported for 2024.
Q4 2024 revenue $613 million, up 6%; full-year revenue $2.4 billion, up 12%
Q4 GAAP diluted EPS $1.26, up $0.30; full-year GAAP diluted EPS $5.18, up $3.07
Full-year 2024 non-GAAP diluted EPS $5.62; 2025 outlook $5.20 to $5.60 on revenue of $2.4 billion to $2.5 billion
Total backlog a record $4.7 billion at December 31, 2024
Pinnacle West reported full-year 2024 net income attributable to common shareholders of $608.8 million, or $5.24 per diluted share, up from $501.6 million, or $4.41, in 2023. The company posted a fourth-quarter net loss of $6.8 million, or $0.06 per diluted share, and said it continues to estimate 2025 earnings of $4.40 to $4.60 per diluted share on a weather-normalized basis.
Full-year 2024 net income attributable to common shareholders was $608.8 million, or $5.24 per diluted share, versus $501.6 million, or $4.41, in 2023.
Fourth-quarter 2024 net loss attributable to common shareholders was $6.8 million, or $0.06 per diluted share, compared with a net loss of $23,000 in the fourth quarter of 2023.
Full-year 2024 operating revenues were $5.12 billion, up from $4.70 billion in 2023; fourth-quarter revenues were $1.10 billion, up from $991.6 million.
2025 EPS guidance of $4.40 to $4.60 per diluted share was reiterated in the company's February 25, 2025 release.
Harmony Biosciences reported fourth-quarter and full-year 2024 results, with WAKIX net product revenue of $201.3 million for the quarter, up 20% from a year earlier, and $714.7 million for the year, up 23%. The company reiterated its 2025 WAKIX net revenue guidance of $820 million to $860 million and said it reached a settlement in its first generic patent litigation. Quarterly GAAP diluted earnings per share were $0.85, up from $0.45, while full-year 2024 GAAP diluted EPS was $2.51, up from $2.13.
Q4 2024 net product revenue was $201.3 million, compared with $168.4 million in Q4 2023.
Q4 2024 GAAP net income was $49.5 million, or $0.85 per diluted share, versus $26.6 million, or $0.45, a year earlier.
Full-year 2024 net product revenue was $714.7 million; 2025 WAKIX net revenue guidance is $820 million to $860 million, reiterated, not changed.
Full-year 2024 GAAP net income was $145.5 million, or $2.51 per diluted share, including a $25.5 million upfront licensing fee and a $17.1 million IPR&D charge within R&D expenses.
DigitalOcean reported fourth-quarter revenue of $205 million, up 13% year-over-year, and full-year 2024 revenue of $781 million, also up 13%, with full-year net income of $84 million. The company initiated first-quarter and full-year 2025 guidance, with 2025 total revenue expected at $870 million to $890 million, and non-GAAP diluted net income per share of $1.85 to $1.95. Separately, director Amy Butte said she will not stand for reelection at the 2025 Annual Meeting, citing no disagreement with the company.
Q4 2024 revenue was $205 million, up 13%; net income attributable to common stockholders was $18 million, up 15%; diluted EPS was $0.19 versus $0.17 a year earlier.
Full-year 2024 revenue was $781 million, up 13%; net income was $84 million; diluted EPS was $0.89 versus $0.20 in 2023.
First-quarter 2025 guidance: total revenue of $207 million to $209 million. Full-year 2025 guidance: total revenue of $870 million to $890 million.
Director Amy Butte, who joined the board in April 2018, notified the company on February 21, 2025 that she will not stand for reelection and will serve through the 2025 Annual Meeting.
Easterly Government Properties reported fourth-quarter 2024 net income of $5.7 million ($0.05 per share fully diluted) and Core FFO of $32.6 million ($0.29 per share). The company raised the lower end of its 2025 Core FFO per share guidance, now $1.18 to $1.21, and the board approved a $0.265 per share dividend for the fourth quarter.
Q4 2024 net income of $5.7 million, or $0.05 per share; Core FFO of $32.6 million, or $0.29 per share
Full-year 2024 net income of $20.6 million ($0.19 per share) and Core FFO of $126.9 million ($1.17 per share); results were at the upper end of raised guidance
2025 Core FFO per share guidance of $1.18 to $1.21 after raising the lower end; assumes $100 million of wholly owned acquisitions
Quarterly dividend of $0.265 per share, payable March 17, 2025 to holders of record on March 5, 2025
Planet Fitness reported fourth-quarter 2024 revenue of $340.5 million, up 19.4% from a year earlier, and net income attributable to the company of $47.1 million, or $0.56 per diluted share, versus $0.41 a year earlier. For full-year 2024, revenue rose 10.3% to $1.2 billion and diluted EPS was $2.00, compared with $1.62, and the company gave 2025 growth expectations including revenue up approximately 10% and adjusted net income per diluted share up 11% to 12%.
Q4 2024 total revenue rose $55.4 million, or 19.4%, to $340.5 million; equipment segment revenue rose 49.2% to $105.1 million
Full-year 2024 net income attributable to Planet Fitness was $172.0 million, or $2.00 per diluted share, versus $138.3 million, or $1.62, in 2023
2025 outlook calls for same club sales growth of 5% to 6%, revenue up approximately 10%, and adjusted net income per diluted share up 11% to 12%
The company opened 150 clubs in 2024 and ended the year with 19.7 million members
LivaNova reported fourth-quarter revenue of $321.8 million, up 3.8%, and full-year 2024 revenue of $1.25 billion, up 8.7%. Full-year 2024 adjusted diluted EPS was $3.38, up from $2.80, and the company guided to 2025 adjusted diluted EPS of $3.65 to $3.75, which is above the 2024 figure.
Q4 2024 revenue $321.8 million, up 3.8% reported; GAAP diluted EPS $1.02 versus $0.30; adjusted diluted EPS $0.81 versus $0.87
Full-year 2024 revenue $1.25 billion, up 8.7%; GAAP diluted EPS $1.16; adjusted diluted EPS $3.38 versus $2.80
2025 guidance: revenue growth of 5.0% to 6.0% on a constant-currency basis; adjusted free cash flow of $135 million to $155 million
Armstrong World Industries reported fourth-quarter 2024 net sales of $367.7 million, up 17.7%, and diluted net earnings per share of $1.42, up 34.0%. For full-year 2024, net sales rose 11.6% to $1,445.7 million and adjusted diluted EPS rose 18.6% to $6.31, and the company issued 2025 guidance calling for adjusted diluted EPS of $6.85 to $7.15.
Q4 2024 net sales $367.7 million, up 17.7%; diluted EPS $1.42 versus $1.06 a year earlier
Full-year 2024 adjusted diluted EPS $6.31 versus $5.32, up 18.6%
2025 guidance: net sales $1,570 million to $1,610 million; adjusted diluted EPS $6.85 to $7.15
$662 million remained under the share repurchase authorization as of December 31, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.